{"id":"W4408502164","doi":"10.1038/s43018-025-00921-6","title":"Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial","year":2025,"lang":"en","type":"article","venue":"Nature Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; University of Alberta","funders":"Regeneron Pharmaceuticals","keywords":"Refractory (planetary science); Medicine; Internal medicine; Oncology; Diffuse large B-cell lymphoma; Lymphoma; Phases of clinical research; Clinical trial; Primary (astronomy); Materials science; Physics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003622574,0.0002569176,0.0007338481,0.0008938978,0.00005125355,0.00002391008,0.0001386322,0.000450165,0.0004911537],"category_scores_gemma":[0.00005239935,0.00020167,0.0001111934,0.001935167,0.00007150111,0.00009991019,0.00004807085,0.0009347489,0.000001473924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001112428,"about_ca_system_score_gemma":0.0004944228,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001495547,"about_ca_topic_score_gemma":0.0005489862,"domain_scores_codex":[0.9979452,0.000147284,0.0003921213,0.0005677004,0.0005124184,0.0004352461],"domain_scores_gemma":[0.9989787,0.0002040254,0.00009779813,0.0004816822,0.0001137741,0.0001239784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5947444,0.02386314,0.2589668,0.0001971885,0.001024971,0.00008857661,0.000800741,0.00002068748,0.003017305,0.00002272351,0.001042165,0.1162112],"study_design_scores_gemma":[0.5767452,0.0007775474,0.3928185,0.0001200316,0.00024195,1.975199e-7,0.0000227562,0.0001034551,0.000393486,0.000005425868,0.02859182,0.0001797574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893823,0.006982325,0.0000225545,0.0003557784,0.0001784907,0.001595061,0.00007903566,0.0000280728,0.001376356],"genre_scores_gemma":[0.993381,0.001686664,0.00005783252,0.001223083,0.0001104833,0.0001002028,0.0001672054,0.00003798876,0.003235599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1338516,"threshold_uncertainty_score":0.8223865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006223594720564041,"score_gpt":0.3084274952527611,"score_spread":0.3022039005321971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}